ExodusPoint Capital Management »

Celldex Therapeutics shares owned by ExodusPoint Capital Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by ExodusPoint Capital Management from 13F filings

Historical chart of ExodusPoint Capital Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by ExodusPoint Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by ExodusPoint Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $436k 17k 25.28
2023-09-30 $727k 26k 27.50
2021-03-31 $2.8M 136k 20.60
2020-12-31 $3.0M 171k 17.52
2020-06-30 $759k 58k 12.99

More positions owned by ExodusPoint Capital Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ameren Corporation (AEE)
Merck & Co Call Option (MRK)
Nebius Group Shs Class A Put Option (NBIS)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Procter & Gamble Company (PG)
Evergy (EVRG)
Microsoft Corporation Put Option (MSFT)

View all positions for ExodusPoint Capital Management

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Point72 Asset Management
Bellevue Group
Commodore Capital
State Street Corporation
Deep Track Capital
Eventide Asset Management
Geode Capital Management
Polar Capital Holdings
Pictet Asset Management Holding SA
Vestal Point Capital

View all funds holding Celldex Therapeutics